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Background/aim: Quorum sensing (QS) is a chemical communication process that bacteria use to regulate virulence. Inhibition of QS
(antiQS) overcomes the pathogenicity of bacteria. Silver nanoparticles (AgNPs) have been used as antimicrobials against pathogens,
but have not been used against QS-mediated bacterial infection. Also, studies have been carried out on the inhibitory effects of propolis
based structures on pathogen growth, but no studies have been found on their potential use as QS inhibitor. The present study aims to
investigate the synthesis and characterization of silver nanoparticles (AgNPs) reduced with propolis extract (P–AgNPs) and evaluation
of their antimicrobial and, for the first time, antiQS activity.
Materials and methods: P–AgNPs were synthesized using with different volumes (1, 2.5 and 5 mL) of propolis extract (PE) by biological
method via reduction of silver nitrate. Synthesized P–AgNPs were characterized in terms of hydrodynamic, chemical, morphological,
physical, and antioxidant properties. Disc diffusion and flask incubation assays were used to evaluate the antimicrobial effect against
Gram–negative bacteria (Escherichia coli, Proteus mirabilis, Proteus vulgaris, Salmonella typhimurium, Enterobacter aerogenes,
Pseudomonas aeruginosa) and Gram–positive bacteria (Staphylococcus aureus, Streptococcus mutans, Bacillus thuringiensis) and QS–
regulated biofilm activity against biosensor strain Chromobacterium violaceum CV026.
Results: AgNPs were successfully synthesized by biological method via PE. The violacein pigment production based on the QS system
was greatly inhibited by the P–AgNPs (inhibition zones: 16.22-21.48 mm and violacein inhibition: 63.16 ± 2.4-75.24 ± 3.5 %) without
interfering with the growth of bacteria, which is the first report on the antiQS effect of P–AgNPs.
Conclusion: Our results suggest that P–AgNPs may be potentially used to inhibit bacterial physiological processes due to the signal
molecules regulates important collective behavior of bacteria. The development of such nontoxic biomaterials may have great potential
to evaluate for the new medicinal substance that inhibits the pathogenic biofilms.
Key words: silver nanoparticles, quorum sensing, virulence factor, antimicrobial agent, propolis

1. Introduction
Nanotechnology is the science of achieving the
materials more functional by taking advantage of their
nanodimensional properties. Due to this dimension,
they can be used in many different ways with more
sufficient and unique functions. Surface properties
are the most favored and attractive parts of current
nanoscience at the nanoscale. In addition, improving
the materials with many different modification methods
makes the nanostructure more biocompatible and using
them with natural and biological components are one of
the advantageous and practical ways for biomedical and
biological applications.

Metal nanoparticles such as silver, gold, titanium,
iron, etc. are one of the most used materials among all the
nanostructures. They have many different specific usage areas
due to their unique natures. The medical science is seeking
new promising approaches with the rising importance
of bacterial resistance against most of the antibiotics [1].
Especially, AgNPs have always aroused great interest
among the researchers with their antimicrobial, antifungal,
and antiviral properties. Nanosilver systems have gained
a reputation due to their respectable activity against many
microorganisms, even in case of a low dose [2]. Synthesis and
usage are very inexpensive and practical. Silver shows very
little toxicity for humans with a small number of doses [3].
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Propolis is a sticky substance collected by honeybees.
Propolis has been used traditionally as a natural remedy for
the treatment of a variety of diseases through the inclusion
of a large number of active compounds, such as flavonoids.
Through contained flavonoids, propolis becomes highly
effective against antibiotic resistant bacterial strains
[4,5]. Propolis is commercially available in several forms
in folk medicine due to its medical advantages such
as antiinflammatory, antioxidant, antimicrobial, and
cytostatic effects. The antimicrobial activity of propolis
against many pathogens has been studied and widely
known for many years [6]. Recently, the inhibitory effects
of propolis based nanostructures on pathogens have been
studied [7,8], but still, there is a lack of a nanotechnological
knowledge about propolis and its medicinal and biological
activities with nanostructures.
Interfering with the bacterial communication system
(Quorum Sensing) is one of the alternatives to bacterial
biofilm formation inhibition [9, 10]. QS is described as
a signaling mechanism in bacteria that is an important
regulator for biofilm formation as well as other bacterial
behaviors [11]. The antiQS system provides a new
strategy to prevent diseases of bacteria regulated by signal
molecules at the early stages of bacterial infections [12].
An important advantage of the antiQS applications for
the development of bacterial resistance is that they do
not impose a high selective pressure as antibiotics. Both
AgNPs and propolis show great antimicrobial activities,
but the main difference between these microbial effects is
the way they are used.
While propolis can demonstrate its antimicrobial
effects by its flavonoids, AgNPs demonstrate them with the
reducing agents which are used in the synthesis of them
[13]. In literature, there have been several antimicrobial
studies of propolis and AgNPs and also their combined
form by bacterial growth dependent manner, however
there has been not any studies of P–AgNPs formulation
on the effect of bacterial signal molecule inhibition which
regulates biofilm formation of several pathogenic bacteria.
For this purpose, in this study, we aimed to develop
the potential use of silver nanoparticles synthesized by
propolis extract (PE) as bacterial signal molecule inhibitor
(antiQS) molecule. Thus, in this work, we synthesized
biocompatible, nontoxic, and nonreactive nanoparticulate
material based on AgNPs covered with propolis which
inhibits bacterial growth against several human pathogens
and, as the first time, blocks bacterial signal molecules
against biomonitor strain Chromobacterium violaceum
CV026. P–AgNPs with different volumes (1, 2.5 and 5 mL)
of PE were prepared by biological synthesis method. The
study also includes the characterization of the materials in
terms of physicochemical structure-property-functionality
relationships. This work opens the way to controlling
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bacterial behavior by affecting their communication
using nontoxic and inexpensive substances included
nanomaterials.
2. Materials and methods
2.1. Materials
Silver nitrate (AgNO3) was purchased from Fluka. Sodium
borohydride (NaBH4), Luria Bertoni (LB) agar, MüllerHinton medium were purchased from Sigma-Aldrich.
Other chemicals and solvents were of analytical reagent
grade. Propolis was obtained from the Black Sea region of
Turkey by Professor Necdet Sağlam.
2.2. Synthesis of P–AgNPs
For the synthesis of P–AgNPs, firstly, PE was prepared as
follows: propolis pieces (30g) were grounded well in pestle.
Propolis was dissolved and extracted by ethanol (70%) and
then, this solution was sonicated (Bransonic 220) using
ultrasonic bath and stirred at room temperature for 1 h.
Then the propolis solution was collected and stored at +4
°C. Following that, the solution was mixed overnight in
the dark then filtered through Whatman filter paper. In
this study, we tested the effect of PE volume in constant
amount of AgNPs formulation by means of physical,
chemical and morphological structure and also biological
activity as antimicrobial and antiQS molecule. Thus, we
evaluated the different volumes of PE (1, 2.5, and 5 mL)
for the synthesis of P–AgNPs. NaBH4 was used for the
chemical reduction of silver salt into AgNPs. The synthesis
steps can be described as follows: 30 mL of 2 mM NaBH4
was prepared in ice bath on a stir plate. Then, 2 mL of 1
mM AgNO3 was rapidly added into the solution to reduce
silver ion and to obtain a yellow solution of AgNPs. For the
synthesis of the P–AgNPs, a certain volume of the PE (1,
2.5, and 5 mL) was added to the AgNO3 (10-3M) aqueous
solution. The solution was stirred for 15 min at room
temperature. The AgNPs prepared using different amounts
of PE (1, 2.5, and 5 mL) were called P–AgNPs1, P–AgNPs2,
and P–AgNPs3 in our manuscript, respectively.
2.3. Characterization of hydrodynamic diameters and
concentration
The zeta potential, size, and polydispersity index (PDI) of
the prepared P–AgNPs1, P–AgNPs2, and P–AgNPs3 were
analyzed in a capillary cell by dynamic light scattering
(Zetasizer Nano ZS, Malvern Instruments, UK) at 25 °C.
The measurements were done in triplicate. The results were
demonstrated as values with a mean ± standard deviation.
The concentrations of prepared P–AgNPs1, P–AgNPs2,
and P–AgNPs3 were determined by inductively coupled
plasmon resonance (ICP-MS) (Perkin Elmer, Optima 4300
DV). The experiments were replicated 3 times.
2.4. Trolox equivalent antioxidant capacity (TEAC)
For the TEAC assay, firstly ABTS (2,2-Azino-bis-3ethylbenzothiazoline-6-sulfonic acid) was dissolved in
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a buffer of acetate and added into potassium persulfate
according to Ozgen, Reese [14] with some modifications.
The prepared ABTS containing potassium per sulfate
solution was diluted in 20 mM sodium acetate buffer (pH
4.5) to an absorbance of 0.700 ± 0.01 at 734 nm. Finally,
2.97 mL of the ABTS∙+ solution and 30 mL of pure PE and
prepared nanoparticle solutions (P–AgNPs1, P–AgNPs2,
and P–AgNPs3) were mixed and allowed to stay for 10 min,
and the absorbance was determined at 734 nm by using
UV/Vis spectrophotometer (PG, T60). The measurements
were done in triplicate.
2.5. Characterization of hydrogen bonding
The hydrogen bonding of pure PE, AgNPs, P–AgNPs1,
P–AgNPs2, and P–AgNPs3 were evaluated by using
Fourier Transform Infrared Spectroscopy (FTIR, Perkin
Elmer Nicolet 520 spectrophotometer, Boston, USA). The
samples were analyzed in the range of 450-4000 cm-1 with
4 cm-1 resolution, using 16 scans for the FTIR analysis. The
measurements were replicated 3 times.
2.6. Morphological observations
Scanning Electron Microscopy (SEM) (Zeiss, Evo 40) was
used for the evaluation of the surface morphology of the
synthesized P–AgNPs1, P–AgNPs2, and P–AgNPs3. For
the SEM measurements, nanoparticles were mounted
onto aluminum pin type stubs (diameter: 12 mm) with
carbon tape, and then nanoparticles were coated with
palladium–gold. Transmission Electron Microscopy
(TEM) (FEI Tecnai G2 Spirit BioTwin, USA) was used
for the characterization of the inner morphology of the
P–AgNPs1, P–AgNPs2, and P–AgNPs3. The nanoparticle
solutions were sonicated for 10 s, and 10 mL of each 1 was
taken and then placed onto the copper grid and dried
at room temperature for the TEM analysis. Then, it was
analyzed by the High Contrast Transmission Electron
Microscope (CTEM).
2.7. Antimicrobial activity of P–AgNPs
The following microorganisms including Escherichia coli
(E. coli) ATCC 25922, Staphylococcus aureus (S. aureus)
ATCC 25923, Streptococcus mutans (S. mutans) ATCC
25175, Proteus mirabilis (P. mirabilis) ATCC 14153,
Salmonella enterica serotype typhimurium (S. typhimurium)
SL 1344, Proteus vulgaris (P. vulgaris) ATCC13315,
Bacillus thuringiensis (B. thuringiensis), Enterobacter
aerogenes (E. aerogenes) ATCC13048, and Pseudomonas
aeruginosa (P. aeruginosa) ATCC 27853 were used as the
tested microorganisms. Bacteria were subcultured on
LB agar at 37 °C for 24 h. Antimicrobial activities of PE,
AgNPs and the synthesized P–AgNPs1, P–AgNPs2, and
P–AgNPs3 against the bacteria were evaluated by the test
of the disc diffusion according to the reference method of
the National Committee for Clinical Laboratory Standards
(NCCLS) [15]. The microorganisms’ turbidity was
modified by 0.5 McFarland standards. The bacteria culture

(100 mL) was swabbed (106 cells/mL) onto Müller-Hinton
agar of Petri plate and filter discs (6 mm in diameter)
within nanoparticles were placed on the inoculated agar
and incubated at 37 °C. The disc with gentamicin (10 mg/
disc) as positive control and only solvent (diluted ethanol)
as negative control were used. All tests were replicated 3
times. The results were demonstrated as the mean diameter
of the inhibition zone in mm ± standard deviation (mean
± SD).
2.8. AntiQS bioassay of nanoparticles
The Chromobacterium violaceum (C. violaceum) CV026
as reporter strain and C. violaceum ATCC 12472 as
biomonitor strain were used to determine the antiQS
properties of P–AgNPs1, P–AgNPs2, and P–AgNPs3, only
PE and AgNPs. The suspension of bacteria was subcultured
by overnight culture (30 °C) in Luria-Bertani (LB) broth.
Disc diffusion test was carried out to evaluate the antiQS
activity of synthesized nanoparticles. For the test, firstly,
C6-HSL (0.25 mg/mL) as signal molecules was added
to LB agar. The strain C. violaceum CV026 was swabbed
onto the prepared Petri plates. Then, discs were taken onto
the Petri plates and the samples (20 mL) were loaded and
incubated at 30 °C for 30 h. Gentamicin as positive control
and only solvent as negative control (diluted ethanol) were
used. Halo formation with a purple background around
the discs revealed that the tested samples exhibited an
antiQS effect. All tests were replicated 3 times. The results
were demonstrated as the mean diameter of the inhibition
zone in mm ± standard deviation (mean ± SD).
The quantitative evaluation of violacein inhibition
of the prepared samples was evaluated C. violaceum
ATCC 12472. The violacein concentration inhibition was
determined according to the reference literature proposed
by İlk, Sağlam [16]. The samples’ suspension was poured
to the C. violaceum ATCC12472 culture. As negative and
positive control, only solvent and gentamicin (10 mg/mL)
were used, respectively. After incubation, the violacein
extraction was done. Culture from each sample was
centrifuged (13552 RCF, 10 min) in order to precipitate the
insoluble violacein and bacterial cells. Then, the phase of
supernatant was discarded, and the pellet was centrifuged.
The supernatant’s absorbance was measured at 585 nm
using a UV/Vis spectrophotometer (PG, T60). The test
was done 3 times. The results were demonstrated as the
mean diameter of the inhibition zone in mm ± standard
deviation (mean ± SD). The violacein inhibition (VI)
was expressed as a percentage. The percent inhibition of
violacein was evaluated by the following formula:
VI% = ((control(OD585)–test(OD585))/control(OD585))
× 100 (Eq. 1)
2.9. Statistical analysis
Statistical analysis to compare size and zeta values of P–
AgNPs and antimicrobial inhibition zone values (mm)

1149

İLK et al. / Turk J Med Sci
against 2 groups (Gram–positive and Gram–negative)
bacteria of P–AgNPs was performed using “IBM SPSS
Statistics ANOVA” and “IBM SPSS Statistics-independent
sample t test” programs, respectively. The significance level
was accepted as P <0.05.
3. Results
3.1. Characterization of P–AgNPs
P–AgNPs were prepared using bioactive components of
PE that reduced AgNO3. The results indicated that when
the amount of AgNO3 was constant, the hydrodynamic
diameter of nanoparticles was highly influenced by the
PE volume (Figure 1). A linear relationship was observed:
increasing PE volumes in AgNPs formulations led to
decreasing values of particle size and polydispersity
index. The formulations containing 1, 2.5, and 5 mL of
PE in a constant amount of AgNO3 suspension (1 × 10-3
M) presented low polydispersity index (PDI ≤ 0.4, data
not shown) within average sizes of 150.90, 82.26, and
47.72 nm for the P–AgNPs1, P–AgNPs2, and P–AgNPs3,
respectively. The aggregation behavior of P–AgNPs was
observed with values higher than 2.5 mL amount of PE
(PDI: 0.82) in a constant amount of AgNPs. When zeta
potential value studies of P–AgNPs were examined,
nanoparticles indicated to have negative zeta-potential
values from -5.37 to -27.9 mV at different volumes of
PE (1 to 5 mL), illustrating that P–AgNPs had negative
surface energy as suggested due to excess negative charges
of AgNO3 molecules after bonding with propolis hydrogen
ions (Figure 1). When the results of size values of P–AgNPs
were compared with their zeta potential, the values of each
AgNPs were not statistically significant (P = 0.0982). The
negative charge values of nanoparticle decreased linearly
with the increasing volume and mass ratio of PE in AgNPs
formulations. Nanoparticles (P–AgNPs1, P–AgNPs2, and
P–AgNPs3) were prepared by using increasing volumes
of PE (1, 2.5, and 5 mL) at a constant amount of AgNO3.
However, after nanoparticle fabrication, the content of
Ag molecules was changed (Table 1) due to the repulsion
between the groups of positive charges of propolis and
negative charge of AgNO3.
The TEAC assay was used to evaluate the antioxidant
capacity of P–AgNPs1, P–AgNPs2, and P–AgNPs3 in
different PE volumes to donate protons. The TEAC assay
indicated that the phenolic group’s capacity of PE donated
and saturated hydrogen in order to stabilize free radicals
(Figure 2). P–AgNPs1 (0.44 mmol TE/g dw), P–AgNPs2
(0.98 mmol TE/g dw), and P–AgNPs3 (2.54 mmol TE/g
dw) were capable of reducing higher values of TEAC
molecules [14].
FTIR analysis was performed to investigate possible
reactions between pure PE, AgNPs, and P–AgNPs1,
P–AgNPs2, and P–AgNPs3 at different volumes of PE
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Figure 1. Average size (grey bars) and surface charges (black
squares) of P–AgNPs1, P–AgNPs2, and P–AgNPs3 in different
volume of PE (1, 2.5, and 5 mL, respectively) (P > 0.05).

Table 1. Concentration of Ag molecules (mg/mL) in P–AgNPs.
Nanoparticles

mg/mL

P–AgNPs1

121 ± 2

P–AgNPs2

114 ± 1

P–AgNPs3

99 ± 5

Figure 2. Trolox equivalent antioxidant capacity of P–AgNPs1,
P–AgNPs2, and P–AgNPs3 in different volume of PE (1, 2.5, and
5 mL, respectively).

(Figure 3). The FTIR spectrums of P–AgNPs1, P–AgNPs2,
and P–AgNPs3 (Figures 3a, 3b, and 3c) displayed similar
absorbance peaks: 3250 cm-1 (O-H stretch) and 1650 cm-1
(C=O bands). The AgNPs spectrum (Figure 3d) indicated

İLK et al. / Turk J Med Sci

Figure 3. FTIR spectrum of P–AgNPs1 (a), P–AgNPs2 (b), P–AgNPs3 (c),
AgNPs (d), and PE (e).

typical 3250 cm -1 (O-H stretch), 1654 cm-1 (C=O bands),
1601 cm-1 (C=C), and 1054 cm-1 (C-O stretch). The PE
spectrum (Figure 3e) shows the characteristic absorption
bands and specific molecular peaks of its chemical
structure: 3300 cm-1 (O-H stretch), 2970 cm-1 (C-H
stretch), 1675 cm-1 (C=O bands), 1604 cm-1 (C=C), 1157
cm-1 (C-O-C), 1067 cm-1 (C-O stretch). Furthermore, P–
AgNPs1, P–AgNPs2, and P–AgNPs3 spectrum displayed
that the C=O absorption band at 1675 cm-1 of propolis
shifted to 1654 cm-1 and the C-O-C and C-O stretch of
propolis completely disappeared at 1157 cm-1 and 1067
cm-1, respectively (Figures 3a, 3b, 3c, and 3e) [17].
From the SEM images of P–AgNPs, it was observed that
P–AgNPs1, P–AgNPs2, and P–AgNPs3 are spherical in
shape, uniform, and polydisperse (Figure 4). SEM images
indicated that an insight into the average size of particles,
which is about 145.90 ± 6.1 nm, 80.62 ± 4.5 nm and 41.27 ±
5.4 nm for the P–AgNPs1 (Figures 4a and 4b), P–AgNPs2,
(Figure 4c and 4d) and P–AgNPs3 (Figure 4e and 4f),
respectively. The results indicated that the high volume of
PE leads to a decrease in the P–AgNPs1, P–AgNPs2, and
P–AgNPs3 size. Similar results were also obtained in zeta
size measurements (Figure 1). On the other hand, in our
study, the inner morphology of the developed P–AgNPs
has been investigated using TEM (Figure 5). Analysis of
the TEM images indicated that the mean particle size
was approximately P–AgNPs1: 14.16 ± 6.74 nm (n = 255)
(Figure 5a and 5b), P–AgNPs2: 14.65 ± 7.46 nm (n = 216)
(Figures 5c and 5d), and P–AgNPs3: 16.42 ± 8.19 nm (n =
288) (Figures 5e and 5f), respectively. AgNPs were dense
and spherical, with a size range between 14–16 nm (Figure
5) [18]. The TEM micrograph also demonstrates that the
AgNPs were surrounded by a thin layer of PE.
3.2. Bioactivity assays of synthesized nanoparticles
Antibacterial activity was screened around AgNPs, pure
PE and synthesized P–AgNPs1, P–AgNPs2, P–AgNPs3

inoculated discs against bacteria and expressed as a
diameter of inhibition zone (mm). The data present that
there is a significant difference in sensitivity between the
Gram–positive and Gram–negative bacteria in the tested
samples (Table 2). The antibacterial properties of samples
are higher against Gram–negative (Gram-) bacteria than
against Gram–positive bacteria (Gram+). In Grambacteria, P. aeruginosa was found to be the most sensitive
bacteria in the tested microorganisms against fabricated
P–AgNPs1, P–AgNPs2, and P–AgNPs3 (14.98 ± 0.95,
20.37 ± 1.12, 27.96 ± 1.44 mm, respectively). Moreover, B.
thuringiensis was found to be the most resistant bacteria
on all the tested P–AgNPs1, P–AgNPs2, and P–AgNPs3
(10.89 ± 0.88, 13.17 ± 0.91, 16.85 ± 0.97 mm, respectively)
in Gram+ bacteria. S. aureus and S. mutans demonstrated
nearly similar sensitivity against all tested compounds.
The antiQS activity of pure AgNPs, PE, and P–
AgNPs with different PE contents was determined
against C. violaceum CV026. In the disc diffusion test,
all the nanoparticles showed antiQS activity against C.
violaceum CV026 (Figure 6a). Three concentrations of
tested P–AgNPs displayed the inhibition zone of violacein
production within the range of 16.22–21.48 mm (Figure
6b). P–AgNPs3 containing the highest PE content
presented a significant pigment reduction compared to
other contents of PE according to radios of clearance zone.
The highest values of inhibition of pigment production
were obtained from P–AgNPs3. In addition, interestingly
the pigment inhibition of pure PE displayed lower antiQS
activity than all the P–AgNPs and pure AgNPs illustrated
the lowest antiQS effect than PE (Figures 6a and 6b).
To determine quantitative signal molecule reduction,
the changing of purple pigment concentration was also
evaluated against C. violaceum ATCC 1247. All the tested
P–AgNPs showed a significant inhibition for the violacein
concentration within the range of 63.16 ± 2.4-75.24 ±3.5%
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Figure 4. Surface morphology of P–AgNPs1 (a and b), P–AgNPs2 (c and d), and P–AgNPs3 (e and f).

(Figure 6b). Similarly, pure PE showed lower inhibition of
violacein production (45.14 ± 3.2%) when compared to P–
AgNPs. With regards to results, P–AgNPs3 exerted a higher
pigment inhibition (75.24 ± 3.5%) against C. violaecum
CV026 and antimicrobial activity (Table 2) against tested
pathogen bacteria when compared to P–AgNPs2 and P–
AgNPs1, which demonstrated antibacterial activity along
with the antiQS activity.
4. Discussion
In this study, P–AgNPs were synthesized using green
synthesis method, which is known as a rapid, cheap,
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and easy fabrication route. It is easy to make changes in
parameters in this method and therefore, surface charge
and size values of P–AgNPs can be controlled by changing
parameters such as PE amount. The hydrodynamic
parameters are presumed to be the essential properties
for the nanoparticle evaluation because they affect
the capacity of stability, encapsulation, and release
of nanoparticles. Additionally, the zeta potential and
particle size induce antimicrobial properties against
microorganism [19]. Nanoparticles within decreasing
size present increasing surface area/volume ratio and
encapsulation capacity, which leads to high release

İLK et al. / Turk J Med Sci

Figure 5. TEM images and size distribution of P–AgNPs1 (a and b), P–AgNPs2 (c and d), P–
AgNPs3 (e and f).
Table 2. Antimicrobial activities of P–AgNPs, PE, AgNPs expressed as inhibition zone diameter (mm) (P <0.05). Statistical analysis
(IBM SPSS Statistics-independent sample t test) of antimicrobial inhibition zones (mm) P–AgNPs1, P–AgNPs2, P–AgNPs3 in 2 groups
of Gram–positive and Gram–negative microorganisms.
Microorganisms

P–AgNPs1

P–AgNPs2

P–AgNPs3

PE

Escherichia coli (Gram-)

13.27 ± 0.92

18.72 ± 1.14

24.65 ± 1.22

11.02 ± 0.87 12.51 ± 0.91

-

30.56 ± 0.24

Salmonella typhimurium (Gram-)

12.86 ± 0.86

17.35 ± 1.02

22.79 ± 1.16

10.86 ± 0.82 11.24 ± 0.90

-

33.12 ± 0.28

Proteus mirabilis (Gram-)

10.95 ± 0.72

14.36 ± 0.98

18.29 ± 1.07

10.07 ± 0.80 10.16 ± 0.86

-

31.47 ± 0.22

Proteus vulgaris (Gram-)

11.88 ± 0.81

15.42 ± 1.06

19.08 ± 1.09

10.92 ± 0.78 11.04 ± 0.88

-

32.45 ± 0.23

Pseudomonas aeruginosa (Gram-)

14.98 ± 0.95

20.37 ± 1.12

27.96 ± 1.44

12.16 ± 0.85 13.21 ± 0.89

-

27.19 ± 0.20

Enterobacter aerogenes (Gram-)

12.65 ± 0.82

17.18 ± 0.99

22.44 ± 1.21

12.23 ± 0.89 12.18 ± 0.91

-

30.15 ± 0.21

Staphylococcus aureus (Gram+)

11.82 ± 0.84

14.09 ± 0.90

17.75 ± 1.04

10.52 ± 0.82 10.61 ± 0.84

-

29.27 ± 0.20

Streptococcus mutans (Gram+)

11.05 ± 0.89

13.94 ± 0.88

17.06 ± 0.95

10.59 ± 0.82 10.83 ± 0.82

-

30.05 ± 0.21

Bacillus thuringiensis (Gram+)

10.89 ± 0.88

13.17 ± 0.91

16.85 ± 0.97

10.02 ± 0.84 10.43 ± 0.84

-

29.72 ± 0.21

efficiency. However, nanoparticles which have decreasing
nanosized diameter can also present more aggregate
structure for long-term applications. The nanoparticles
with low polydispersity index (PDI ≤ 0.1-0.6) properties
can solve this aggregation problem and achieve maximum
stability. All concentrations of tested P–AgNPs had PDI
value up to 0.4 within sizes ranged from 47.72-150.90 nm.
However, the PE volume above 2.5 mL presented aggregate
structure (PDI ≥ 0.8) due to blocking behavior of repulsive
forces with the AgNPs due to decreasing of inter-space
between nanoparticles, thus leading to aggregation. Similar

AgNPs

Control Gentamicin

results were observed by Raffa, Iannuzzo [20] for AgNPs
with a high loading of agents. The size of P–AgNPs can
be manipulated easily for industrial applications. It could
be caused by the fact that in nanoparticle engineering
systems, propolis was in equilibrium with the constant
amount of AgNO3, and above this volume, PE reached
saturation within AgNO3 molecules. Hence, P–AgNPs
with increasing PE amounts were presented that the
increasing values surface charge. Zeta potential provides
key information for the antimicrobial effect of agents
through the interaction with microbial cell surface [21].
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Figure 6. Disc diffusion assay for the antiquorum sensing activity (a) inhibition zone (mm) (light purple bars), and quantitative
determination of violacein inhibition (%) (black squares) (b) of AgNPs, PE, P–AgNPs1, P–AgNPs2, and P–AgNPs3.

P–AgNPs1–3 showed that negative zeta-potential values
from -5.37 to -27.9 mV. Similar results were also reported:
AgNPs have negative surface charges at pH 4.5 with zeta
potential values between –5 and -27 mV [22–24].
It was reported that the reducing power is generally
related to the presence of a reductant [25]. Propolis is
considered to have high antioxidant activity. However,
several environmental conditions, especially light and
heat during the preparation process can influence its
antioxidant capacity and limit its application. Biological
active compounds like propolis in nanoparticle formation
can prevent their antioxidant nature due to hydrogen
bonding between them and nanoparticle core or shell
material. In our study, we found that P–AgNPs had
higher antioxidant capacity (0.44 mmol TE/g dw and 2.54
mmol TE/g dw) with increasing PE volumes from 1 to 5
mL, respectively. From the results, it is observed that the
propolis with different volumes can keep its antioxidant
capacity following nanoparticle synthesis. The hydrogen
bonding interaction between them was also evaluated by
FTIR measurements. The spectroscopy results indicated
that the intramolecular hydrogen bonding was structured
between PE and AgNPs after the formation of P–AgNPs
[18]. Surface properties of nanomaterials have an important
effect on drug release kinetics [26]. Interestingly, when the
results of the size and surface morphology of P–AgNPs
compared with the results data of TEM micrograph, the
size of P–AgNPs within increased amount of PE decreased
from 150.90–47.72 nm, but the size of AgNPs increased
from 14.16–16.42 nm. We suggest that it could be caused
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by the fact that propolis with the constant amount of
AgNO3 was in equilibrium.
The antibacterial activities of P–AgNPs against Grambacteria showed higher zone size than Gram+ bacteria
(P < 0.05). It may be assumed that Gram- bacteria have a
simple cell wall structure which has many pores that can
allow disturbing cell wall and the cytoplasm with different
molecules. We suggest that the results of antimicrobial
activity of P–AgNPs1–3 may be associated with the
disruption of low peptidoglycan structure of bacteria
cell wall since lipid–lipid interactions provide liquidity
of Gram- bacteria cell wall and membrane. This could
stem from the differences in the cell wall structure of
Gram–negative and Gram–positive, considering all of
the incubations were carried out in the same conditions.
Gram- and Gram+ bacteria contain peptidoglycans as part
of their cell walls, but peptidoglycan layers are thin and
low in Gram- and thick and quite compact in Gram+ [27–
29]. However, P. mirabilis displayed stronger resistance
than other bacteria on the tested pure PE, AgNPs, P–
AgNPs1, P–AgNPs2, and P–AgNPs3 because P. mirabilis
can elongate itself and secrete a polysaccharide when
in contact with surfaces. This mechanism of P. mirabilis
provides resistance to items such as antimicrobial agents
[30]. Furthermore, in Gram+ bacteria, B. thuringiensis
showed the highest zone against all the P–AgNPs1–3. This
result indicated that the Bacillus species might be a form of
endospores that are more resistant to biocidal agents than
other bacteria strains [31]. From the results, it was observed
that P–AgNPs1, P–AgNPs2, and P–AgNPs3 within an
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increasing amount of PE resulted in a significant increase
in the antimicrobial zone of all the tested microorganisms.
P–AgNPs3 (within 5 mL PE) showed maximum zone of
inhibition against all tested bacteria than P–AgNPs1 and
P–AgNPs2 (containing 2.5- and 1-mL PE, respectively).
This mechanism was presumed that compounds of the
flavonoids of PE ensure to lysis the cells of bacteria by
binding to the components of the cell wall and causing
disruption of cytoplasm [32]. Also, natural antioxidant
PE within AgNO3 can show a strong antimicrobial effect
against both Gram- and Gram+ bacteria.
The results obtained from antiQS studies exhibited the
potential use of AgNPs covered with PE, for the first time, as
antiQS agents owing to inhibiting the violacein production
without inhibition of bacterial growth. The obtained
antiQS properties of the P–AgNPs may contribute to the
bioactive capacity of polyphenolic rich compounds of PE.
The nontoxic and nonreactive antimicrobial and antiQS
potential of the novel biobased nanoparticle engineering
systems could be useful further for the development of the
therapeutics on the pathogenesis of the tested bacteria.
In conclusion, for the first time, significant inhibition
against the quorum sensing regulated pigment production

of the bacteria C. violaceum CV026 was observed using the
novel P–AgNPs without the addition of any chemical active
agents. Although the exact mechanism for the observed
antiQS effect of the P–AgNPs is still to be unraveled, this
may be related to the affinity of hydroxyl groups such as
phenolic contents including flavonoids, phenolic acids,
anthocyanins, and several aromatic acids of propolis on
the AgNPs surface. Since the autoinducer for the pigment
production of C. violaceum CV026 also regulates many
other important physiological behaviors of bacteria, it is
expected that these new nanoparticles may be potentially
used to inhibit those physiological processes, including
biofilm formation. Besides the applications as packaging
materials, medical textile, or various biomedical devices,
also such sustainable nanoparticles may have the potential
in the development of new antivirulence drugs or additive.
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